Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is 49 924,65 ₴, with a 24-hour trading volume of 174,07B ₴. The asset's market cap is 44,51T ₴, after moving 0.55% in the last day.
Tokenized Eli Lilly And Co is trading at 50 040,14 ₴, with a tokenized market cap of 1,87B ₴ and a 24-hour trading volume of 105,71M ₴. The tokenized asset has moved -3.09% in the past 24 hours.